Lu Peng
Lu Peng, PRES, reported an open-market or private sale at Pharvaris N.V. involving 15000.000000 shares for an estimated $610134.00. Reported holdings after the transaction were 65179.000000 shares. The stored filing text includes a detected 10b5-1 reference.
- Trade date
- Sep 08, 2026
- Filing date
- Sep 09, 2026
How reported position traded is calculated
Shares sold ÷ (holdings after + shares sold). Estimated position before: 80,179 shares.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
PHVS price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- Sell Code S
- Identifier
- 0001193125-26-386096 Common Stock
- Transaction date
- Sep 08, 2026 Filed Sep 09, 2026, 03:19 PM · 1d delay
- Shares
- 15,000 sh $40.68 per share
- Estimated value
- -$610k Computed from shares × price
- Holdings after
- 65,179 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
0 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 1
Filing reported within two business days of the transaction. - tenb5_1_detected-10 points
is_10b5_1 = true
Stored filing content includes detected 10b5-1 language.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
President
- F1
This is a scheduled exercise and sale from 10b5-1 trading plan.
- F2
The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date pursuant to a Rule 10b5-1 trading plan. The shares were sold in connection wit…
- F3
25% of the option vested on February 3, 2021 with the remaining shares vesting in 1/48 monthly installments thereafter.
0 other transactions
0 recent txs